RxDoctor Payments Data

Joseph Kahan, MD

Orthopaedic Surgery · South Portland, MENPI 1336678093

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (39.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Arthrex at 42.8% of the total. Reporting peaked in 2022 at $35,961 and has fallen 92.8% since, to $2,588 in 2025. Among orthopaedic surgery clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,827in general payments, 2019–2025

Across 136 payments — averaging $373.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$22K
  • Smith+Nephew$13K
  • Peerless Surgical Inc.$7K
  • Lima USA, Inc.$2K
  • Exactech, Inc.$2K
  • Stryker$1K
  • plus $4K from 10 others

What the payments were for

  • Grants$20,00039%
  • Travel & lodging$5,89012%
  • Food & beverage$7,27014%
  • Education$17,66735%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,827 in reported general payments places this provider in the 90th percentile of 111 orthopaedic surgery providers in Maine.

See all orthopaedic surgery providers in Maine

Medicare billing

Part B allowed, 2024
$58,608
Medicare patients
144
Services billed
372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam13$9

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in South Portland

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →